These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19505378)

  • 1. Pidotimod: a reappraisal.
    Riboldi P; Gerosa M; Meroni PL
    Int J Immunopathol Pharmacol; 2009; 22(2):255-62. PubMed ID: 19505378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pidotimod for the prevention of acute respiratory infections in healthy children entering into daycare: A double blind randomized placebo-controlled study.
    Mameli C; Pasinato A; Picca M; Bedogni G; Pisanelli S; Zuccotti GV;
    Pharmacol Res; 2015 Jul; 97():79-83. PubMed ID: 25931316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of pidotimod in the prevention of recurrent respiratory infections in children: a multicentre study.
    Namazova-Baranova LS; Alekseeva AA; Kharit SM; Kozhevnikova TN; Taranushenko TE; Tuzankina IA; Scarci F
    Int J Immunopathol Pharmacol; 2014; 27(3):413-9. PubMed ID: 25280032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pidotimod may prevent recurrent respiratory infections in children.
    Licari A; De Amici M; Nigrisoli S; Marseglia A; Caimmi S; Artusio L; Marseglia GL
    Minerva Pediatr; 2014 Oct; 66(5):363-7. PubMed ID: 25253184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoactivation by pidotimod in children with recurrent respiratory infections.
    Burgio GR; Marseglia GL; Severi F; De Benedetti F; Masarone M; Ottolenghi A; Pagliano L; Serra U; Nespoli L
    Arzneimittelforschung; 1994 Dec; 44(12A):1525-9. PubMed ID: 7857357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of pidotimod in the treatment of recurrent respiratory infections in children.
    Caramia G; Clemente E; Solli R; Mei V; Cera R; Carnelli V; Venturoli V; Corsini A
    Arzneimittelforschung; 1994 Dec; 44(12A):1480-4. PubMed ID: 7857347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pidotimod: the past and the present.
    Zuccotti GV; Mameli C
    Ital J Pediatr; 2013 Dec; 39():75. PubMed ID: 24314100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of immunoactivation with pidotimod in recurrent respiratory infections in childhood.
    Careddu P
    Arzneimittelforschung; 1994 Dec; 44(12A):1506-11. PubMed ID: 7857353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pidotimod and bifidobacteria mixture on clinical symptoms and urinary metabolomic profile of children with recurrent respiratory infections: a randomized placebo-controlled trial.
    Santamaria F; Montella S; Stocchero M; Pirillo P; Bozzetto S; Giordano G; Poeta M; Baraldi E
    Pulm Pharmacol Ther; 2019 Oct; 58():101818. PubMed ID: 31302340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory activity of pidotimod administered with standard antibiotic therapy in children hospitalized for community-acquired pneumonia.
    Esposito S; Garziano M; Rainone V; Trabattoni D; Biasin M; Senatore L; Marchisio P; Rossi M; Principi N; Clerici M
    J Transl Med; 2015 Sep; 13():288. PubMed ID: 26335787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Pidotimod on recurrent respiratory infections in children with Down syndrome: a retrospective Italian study.
    Valentini D; Di Camillo C; Mirante N; Marcellini V; Carsetti R; Villani A
    Ital J Pediatr; 2020 Mar; 46(1):31. PubMed ID: 32164747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pidotimod, an immunostimulant in pediatric recurrent respiratory tract infections: A meta-analysis of randomized controlled trials.
    Niu H; Wang R; Jia YT; Cai Y
    Int Immunopharmacol; 2019 Feb; 67():35-45. PubMed ID: 30530167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation and changes of the respiratory epithelium function after administration of Pidotimod in Greek children with recurrent respiratory tract infections.
    Aivazis V; Hatzimichail A; Papachristou A; Valeri R; Iuga-Donca G
    Minerva Pediatr; 2002 Aug; 54(4):315-9. PubMed ID: 12131867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pidotimod in the management of recurrent pharyngotonsillar infections in childhood.
    Passali D; Calearo C; Conticello S
    Arzneimittelforschung; 1994 Dec; 44(12A):1511-6. PubMed ID: 7857354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulating activity of Pidotimod in children with Down syndrome.
    Zuccotti GV; Mameli C; Trabattoni D; Beretta S; Biasin M; Guazzarotti L; Clerici M
    J Biol Regul Homeost Agents; 2013; 27(1):253-8. PubMed ID: 23489705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reappraisal of Pidotimod: an immunomodulatory agent with 30-year evidence.
    Marseglia GL; Gelardi M; Santus P; Ciprandi G
    Minerva Med; 2024 Aug; 115(4):503-515. PubMed ID: 39016527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic efficacy and safety of pidotimod in the treatment of urinary tract infections in children.
    Clemente E; Solli R; Mei V; Cera R; Caramia G; Carnelli V; Ruffini E; Venturoli V; Corsini A
    Arzneimittelforschung; 1994 Dec; 44(12A):1490-4. PubMed ID: 7857349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness of pidotimod in combination with bacterial lysates in the treatment of the pfapa (periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis) syndrome].
    Buongiorno A; Pierossi N
    Minerva Pediatr; 2015 Jun; 67(3):219-26. PubMed ID: 25941128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pidotimod in allergic diseases.
    Manti S; Parisi GF; Papale M; Leonardi S
    Minerva Pediatr; 2020 Oct; 72(5):358-363. PubMed ID: 32731733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunostimulants and prevention of recurrent respiratory tract infections.
    Esposito S; Musio A
    J Biol Regul Homeost Agents; 2013; 27(3):627-36. PubMed ID: 24152832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.